Jardiance, with the generic name empagliflozin, is an oral diabetes medication that belongs to a class of drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. It is primarily used to manage blood sugar levels in adults with type 2 diabetes. By inhibiting the SGLT2 protein in the kidneys, Jardiance prevents glucose from being reabsorbed into the blood, promoting the excretion of glucose through urine and thereby lowering blood sugar levels. Additionally, it is used to reduce the risk of cardiovascular death in adults with type 2 diabetes who have established cardiovascular disease. Jardiance is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis. It is often prescribed alongside diet and exercise to improve glycemic control.
When using JARDIANCE, a medication primarily prescribed for type 2 diabetes management, it is crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medicine. This ensures you are aware of the correct dosage and any potential interactions with other medications you might be taking. Inform your doctor about all other medicines you are on to avoid adverse reactions. Common side effects of JARDIANCE include urinary tract infections and dehydration, which could lead to dizziness or fainting. Rare side effects might include a serious condition called ketoacidosis. Given these possible side effects, caution is advised when engaging in activities such as driving or operating heavy machinery until you know how JARDIANCE affects you. Staying hydrated is important while on this medication. Always communicate with your healthcare provider about any concerns or unusual symptoms you experience while taking JARDIANCE.